CareFusion PT Raised to $49.00 at Stifel Nicolaus (CFN)
Analysts at Stifel Nicolaus lifted their price target on shares of CareFusion (NYSE:CFN) from $42.00 to $49.00 in a research report issued to clients and investors on Friday. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 15.32% from the company’s current price.
Shares of CareFusion (NYSE:CFN) opened at 42.49 on Friday. CareFusion has a one year low of $35.01 and a one year high of $45.81. The stock has a 50-day moving average of $44.32 and a 200-day moving average of $41.65. The company has a market cap of $9.964 billion and a P/E ratio of 21.48.
CareFusion (NYSE:CFN) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.79 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.72 by $0.07. The company had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter last year, the company posted $0.55 earnings per share. CareFusion’s revenue was up 24.3% compared to the same quarter last year. Analysts expect that CareFusion will post $2.67 EPS for the current fiscal year.
A number of other analysts have also recently weighed in on CFN. Analysts at Zacks reiterated a “neutral” rating on shares of CareFusion in a research note on Thursday, July 31st. They now have a $47.00 price target on the stock. Separately, analysts at Topeka Capital Markets initiated coverage on shares of CareFusion in a research note on Thursday, June 12th. They set a “hold” rating and a $44.00 price target on the stock. Finally, analysts at Raymond James raised their price target on shares of CareFusion from $48.00 to $50.00 in a research note on Monday, May 19th. They now have a “strong-buy” rating on the stock. Five analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company’s stock. CareFusion presently has a consensus rating of “Buy” and an average price target of $45.17.
CareFusion Corporation (NYSE:CFN) is a global medical technology company.
Receive News & Ratings for CareFusion Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareFusion Co and related companies with Analyst Ratings Network's FREE daily email newsletter.